Pathological complete response after neoadjuvant cyclin-dependent kinase 4/6 inhibitor and neoadjuvant endocrine therapy in locally advanced hormone receptor-positive breast cancer. (2024). Indian Journal of Case Reports, 10(10), 322-324. https://doi.org/10.32677/ijcr.v10i10.4727